Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AKYA NASDAQ:ISO NASDAQ:NAUT NASDAQ:RPID On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKYAAkoya Biosciences$1.29$1.24$0.93▼$3.42$64.44M1.36413,801 shsN/AISOIsoPlexis$0.76$0.86$0.60▼$5.10$30.28M1.3268,375 shsN/ANAUTNautilus Biotechnology$0.73+0.3%$0.76$0.66▼$3.09$91.71M1.42164,043 shs144,786 shsRPIDRapid Micro Biosystems$3.40-0.3%$3.39$0.65▼$4.04$149.02M1.32197,626 shs45,081 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKYAAkoya Biosciences0.00%0.00%+2.38%+17.27%-45.34%ISOIsoPlexis0.00%0.00%0.00%0.00%0.00%NAUTNautilus Biotechnology0.00%-7.22%+1.46%+0.71%-72.22%RPIDRapid Micro Biosystems0.00%+1.49%+2.71%+50.22%+390.86%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAKYAAkoya Biosciences1.6031 of 5 stars3.03.00.00.00.01.70.6ISOIsoPlexisN/AN/AN/AN/AN/AN/AN/AN/ANAUTNautilus Biotechnology3.051 of 5 stars2.55.00.00.01.94.20.6RPIDRapid Micro Biosystems2.4535 of 5 stars2.04.00.00.03.23.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKYAAkoya Biosciences 2.00Hold$2.5194.26% UpsideISOIsoPlexis 0.00N/AN/AN/ANAUTNautilus Biotechnology 1.00Sell$2.13192.30% UpsideRPIDRapid Micro Biosystems 4.00Strong Buy$8.00135.29% UpsideCurrent Analyst Ratings BreakdownLatest ISO, RPID, NAUT, and AKYA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025AKYAAkoya BiosciencesCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$1.80 ➝ $1.084/29/2025AKYAAkoya BiosciencesCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$3.50 ➝ $1.80(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKYAAkoya Biosciences$79.96M0.81N/AN/A$0.15 per share8.60ISOIsoPlexis$16.76M1.81N/AN/A$1.04 per share0.73NAUTNautilus BiotechnologyN/AN/AN/AN/A$1.66 per shareN/ARPIDRapid Micro Biosystems$28.05M5.31N/AN/A$1.75 per share1.94Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKYAAkoya Biosciences-$55.37M-$0.97N/AN/AN/A-59.44%-487.85%-35.86%8/4/2025 (Estimated)ISOIsoPlexis-$106M-$2.70N/AN/AN/A-632.41%-127.86%-71.41%N/ANAUTNautilus Biotechnology-$70.78M-$0.54N/AN/AN/AN/A-31.87%-27.39%7/31/2025 (Estimated)RPIDRapid Micro Biosystems-$46.89M-$1.03N/AN/AN/A-151.22%-56.07%-44.11%8/1/2025 (Estimated)Latest ISO, RPID, NAUT, and AKYA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2025Q2 2025AKYAAkoya Biosciences-$0.22N/AN/AN/A$18.10 millionN/A8/1/2025Q2 2025RPIDRapid Micro Biosystems-$0.26N/AN/AN/A$7.10 millionN/A7/31/2025Q2 2025NAUTNautilus Biotechnology-$0.14N/AN/AN/AN/AN/A5/12/2025Q1 2025AKYAAkoya Biosciences-$0.29-$0.32-$0.03-$0.32$20.19 million$16.64 million5/9/2025Q1 2025RPIDRapid Micro Biosystems-$0.27-$0.26+$0.01-$0.26$6.63 million$7.21 million4/29/2025Q1 2025NAUTNautilus Biotechnology-$0.14-$0.13+$0.01-$0.13N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAKYAAkoya BiosciencesN/AN/AN/AN/AN/AISOIsoPlexisN/AN/AN/AN/AN/ANAUTNautilus BiotechnologyN/AN/AN/AN/AN/ARPIDRapid Micro BiosystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKYAAkoya Biosciences10.120.610.40ISOIsoPlexis1.124.062.50NAUTNautilus BiotechnologyN/A17.3617.36RPIDRapid Micro BiosystemsN/A4.613.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKYAAkoya Biosciences79.42%ISOIsoPlexis44.91%NAUTNautilus Biotechnology50.71%RPIDRapid Micro Biosystems52.60%Insider OwnershipCompanyInsider OwnershipAKYAAkoya Biosciences7.30%ISOIsoPlexis6.40%NAUTNautilus Biotechnology41.10%RPIDRapid Micro Biosystems29.96%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKYAAkoya Biosciences9049.95 million46.31 millionOptionableISOIsoPlexis45939.76 million37.22 millionNot OptionableNAUTNautilus Biotechnology130126.15 million74.30 millionOptionableRPIDRapid Micro Biosystems20043.83 million30.70 millionNot OptionableISO, RPID, NAUT, and AKYA HeadlinesRecent News About These CompaniesRobert G. Jr. Spignesi Sells 11,881 Shares of Rapid Micro Biosystems, Inc. (NASDAQ:RPID) StockJuly 16, 2025 | insidertrades.comRobert G. Jr. Spignesi Sells 11,881 Shares of Rapid Micro Biosystems, Inc. (NASDAQ:RPID) StockJuly 15, 2025 | marketbeat.comRobert G. Jr. Spignesi Sells 11,874 Shares of Rapid Micro Biosystems, Inc. (NASDAQ:RPID) StockJuly 15, 2025 | marketbeat.comInsider Selling: Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Sells 10,824 Shares of StockJuly 11, 2025 | insidertrades.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Robert G. Jr. Spignesi Sells 10,824 SharesJuly 10, 2025 | marketbeat.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Sells $39,476.97 in StockJuly 10, 2025 | marketbeat.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Robert G. Jr. Spignesi Sells 11,617 SharesJuly 10, 2025 | marketbeat.comRapid Micro Biosystems (NASDAQ:RPID) Stock Price Down 0.9% - Here's WhyJuly 10, 2025 | marketbeat.comFavourable Signals For Rapid Micro Biosystems: Numerous Insiders Acquired StockJuly 3, 2025 | finance.yahoo.comRapid Micro Biosystems Grants Equity Awards to New Employee as Inducement for EmploymentJune 13, 2025 | quiverquant.comQRapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 13, 2025 | globenewswire.comRapid Micro Biosystems Appoints Dr. Dafni Bika to Board of DirectorsMay 29, 2025 | nasdaq.comRapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of DirectorsMay 27, 2025 | globenewswire.comEarnings call transcript: Rapid Micro Biosystems Q1 2025 shows revenue growthMay 10, 2025 | investing.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comRapid Micro Biosystems, Inc.: Rapid Micro Biosystems Reports First Quarter 2025 Financial ResultsMay 10, 2025 | finanznachrichten.deWhy Rapid Micro Biosystems, Inc.’s (RPID) Stock Is Up 26.12%May 9, 2025 | aaii.comARapid Micro Biosystems, Inc. (RPID) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comRapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue EstimatesMay 9, 2025 | zacks.comRapid Micro Biosystems Reports First Quarter 2025 Financial ResultsMay 9, 2025 | globenewswire.comRapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025April 24, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeISO, RPID, NAUT, and AKYA Company DescriptionsAkoya Biosciences NASDAQ:AKYA$1.29 0.00 (0.00%) As of 07/8/2025Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.IsoPlexis NASDAQ:ISOIsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.Nautilus Biotechnology NASDAQ:NAUT$0.73 +0.00 (+0.26%) Closing price 04:00 PM EasternExtended Trading$0.74 +0.01 (+1.10%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.Rapid Micro Biosystems NASDAQ:RPID$3.40 -0.01 (-0.29%) Closing price 04:00 PM EasternExtended Trading$3.42 +0.02 (+0.74%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analysts See Upside in These 5 Stocks That Just Raised Dividends MarketBeat Week in Review – 07/14 - 07/18 Q2 Could Be the Catalyst PayPal Investors Have Been Waiting For Kinder Morgan: At the Hotspot of the Natural Gas Revolution Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
